SEC Form 4 · accession 0001771213-26-000002
LB PHARMACEUTICALS INC · LBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rekha Hemrajani
Director
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 5:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001691082
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $27.95 | Jun 3, 2026 | A | 10,000 | A | — | Jun 2, 2036 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1100% of the shares underlying the option vest on the earlier of (i) June 3, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date.